HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis.

AuthorsKayoko Matsumura, Hiroshi Nakase, Shuji Yamamoto, Takuya Yoshino, Yasuhiro Takeda, Katsuhiro Kasahara, Satoru Ueno, Norimitsu Uza, Tsutomu Chiba
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 15 Issue 7 Pg. 967-8 (Jul 2009) ISSN: 1536-4844 [Electronic] England
PMID18942759 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab
Topics
  • Adult
  • Anti-Inflammatory Agents (administration & dosage)
  • Antibodies, Monoclonal (administration & dosage)
  • Colitis, Ulcerative (complications, drug therapy, immunology)
  • Female
  • Humans
  • Hyperthyroidism (drug therapy, etiology, immunology)
  • Infliximab
  • Th1 Cells (drug effects, immunology)
  • Th2 Cells (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: